• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » UPDATE: IntelligentMDx is ahead of schedule in developing its new Swine Flu test

UPDATE: IntelligentMDx is ahead of schedule in developing its new Swine Flu test

August 19, 2009 By MassDevice staff

IntelligentMDx announced that it’s developed an assay solution for influenza that can distinguish seasonal strains from the H1N1 variant, better known as the Swine Flu.

The company said the assay will be available during the autumn flu season and was designed to comply with Food & Drug Administration and other regulatory guidelines.

IntelligentMDx spokeswoman Elizabeth Holland wrote in an email that the test can also detect a patient’s potential resistance or susceptibility to anti-viral medications.

The company is pursuing FDA approval and a CE Mark from the European Union, Holland added, writing that the company is ahead of schedule for getting the test to market.

“We realize the importance of the assay … in light of the heightened concern with the coming flu season and are doing everything within our capacity to pull the timeline in even further,” she wrote.

Intelligent Medical Devices raised $3 million in June from a pair of unidentified investors, taking its total investment nut to $22 million since its 2004* inception.

The company is working on so-called “intelligent” diagnostic kits for rapid tests of infectious diseases. The devices make copies of genetic material from a small number of cells or fluid samples, simultaneously testing them for chemical markers specific to different diseases.

The devices also rely on mathematical algorithms to predict test failure and to simulate outside factors such as genetic mutations or contamination that could affect results. CEO Alice Jacobs and two other Boston-area researchers received a U.S. patent in June 2005 for a prototype of the devices now being readied for production.

The company recently completed renovations at its Cambridge facility, roughly doubling its size to about 18,000 square feet and adding new Biosafety Level 2 (BL2) laboratory space. BL2 labs allow for work on infectious agents, with numerous safeguards built into their designs to keep disease-carrying materials from escaping the workspace as well as preventing outside contamination.

*Correction, 8/20/2009: IntelligentMDx launched in 2004, not 2000 as originally reported. Return to the corrected sentence.

Filed Under: Business/Financial News, Genomics/Molecular Diagnostics Tagged With: Swine Flu

More recent news

  • Medtronic partners with IRCAD on Hugo, Affera surgical training
  • 23andMe co-founder wins bid to take back control of company
  • Neurent Medical opens new manufacturing facility in Ireland
  • Brain Navi wins FDA nod for neurosurgical robot
  • Adona Medical completes enrollment in first-in-human interatrial shunt trial

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy